FR2930153B1 - Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques - Google Patents

Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques

Info

Publication number
FR2930153B1
FR2930153B1 FR0852679A FR0852679A FR2930153B1 FR 2930153 B1 FR2930153 B1 FR 2930153B1 FR 0852679 A FR0852679 A FR 0852679A FR 0852679 A FR0852679 A FR 0852679A FR 2930153 B1 FR2930153 B1 FR 2930153B1
Authority
FR
France
Prior art keywords
wolfberry
drought
treatment
bay extract
keratinic matter
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0852679A
Other languages
English (en)
Other versions
FR2930153A1 (fr
Inventor
Isabelle Castiel
Audrey Gueniche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nestec SA
LOreal SA
Original Assignee
Nestec SA
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec SA, LOreal SA filed Critical Nestec SA
Priority to FR0852679A priority Critical patent/FR2930153B1/fr
Priority to PCT/FR2009/050741 priority patent/WO2009141544A2/fr
Publication of FR2930153A1 publication Critical patent/FR2930153A1/fr
Application granted granted Critical
Publication of FR2930153B1 publication Critical patent/FR2930153B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • A61K36/815—Lycium (desert-thorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
FR0852679A 2008-04-21 2008-04-21 Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques Expired - Fee Related FR2930153B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR0852679A FR2930153B1 (fr) 2008-04-21 2008-04-21 Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques
PCT/FR2009/050741 WO2009141544A2 (fr) 2008-04-21 2009-04-21 Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0852679A FR2930153B1 (fr) 2008-04-21 2008-04-21 Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques

Publications (2)

Publication Number Publication Date
FR2930153A1 FR2930153A1 (fr) 2009-10-23
FR2930153B1 true FR2930153B1 (fr) 2012-05-04

Family

ID=39968048

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0852679A Expired - Fee Related FR2930153B1 (fr) 2008-04-21 2008-04-21 Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques

Country Status (2)

Country Link
FR (1) FR2930153B1 (fr)
WO (1) WO2009141544A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102784259A (zh) * 2012-06-15 2012-11-21 沈士成 一种治疗红肿疔疮的外敷药物
CN105795280B (zh) * 2014-12-30 2019-07-09 广东智多星食品有限公司 一种枸杞提取物的提取方法及其应用
CA3018865A1 (fr) 2016-03-31 2017-10-05 Gojo Industries, Inc. Composition nettoyante stimulant les peptides antimicrobiens
US10874700B2 (en) 2016-03-31 2020-12-29 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
EP3544575A1 (fr) 2016-11-23 2019-10-02 GOJO Industries, Inc. Composition désinfectante comprenant une substance active probiotique/prébiotique
CN106755185A (zh) * 2017-01-05 2017-05-31 青海康普生物科技股份有限公司 一种微生物法提取枸杞多糖产业化生产工艺
WO2019173782A1 (fr) * 2018-03-08 2019-09-12 Plexus Worldwide Llc Compositions et méthodes pour le renouvellement de la peau
JP2024505253A (ja) * 2021-02-01 2024-02-05 アジトラ インコーポレーテッド 遺伝子操作された細菌中でのタンパク質発現を増加させるための方法および組成物
CN112913999B (zh) * 2021-02-26 2023-09-19 安徽工程大学 一种枸杞红枣复合发酵式功能饮品及其制备方法
CN113855581A (zh) * 2021-08-11 2021-12-31 天津市康婷生物工程集团有限公司 一种多功能脂质体及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005079825A1 (fr) * 2004-02-19 2005-09-01 Kikkoman Corporation Remede oral pour la peau contenant de l'extrait de canneberge comme ingredient actif
MY142017A (en) * 2004-03-19 2010-08-16 Nestec Sa Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
US7807625B2 (en) * 2006-01-18 2010-10-05 Grant Industries, Inc Anti-wrinkle composition
KR100753186B1 (ko) * 2006-09-07 2007-08-30 (주)더페이스샵코리아 생약추출 혼합물을 함유하는 피부 노화 방지용 화장료조성물

Also Published As

Publication number Publication date
WO2009141544A3 (fr) 2010-04-22
WO2009141544A2 (fr) 2009-11-26
FR2930153A1 (fr) 2009-10-23

Similar Documents

Publication Publication Date Title
FR2930153B1 (fr) Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour le traitement de la secheresse des matieres keratiniques
FR2937547B1 (fr) Utilisation d'un lysat de microorganisme pour le traitement des peaux grasses
FR2930154B1 (fr) Utilisation d'un extrait de baie, et plus particulierement de wolfberry, pour maintenir et/ou restaurer la tonicite et/ou la fermete de la peau
FR2948565B1 (fr) Composition cosmetique pour le traitement de l'acne comprenant un extrait petidique de schizandra
FR2937536B1 (fr) Utilisation cosmetique d'un lysat de bifidobacterium species pour le traitement du cuir chevelu gras
FR2950529B1 (fr) Procede de deformation permanente des cheveux au moyen d'un mercaptosiloxane, utilisation et composition
FR2907011B1 (fr) Utilisation de la citrulline pour le traitement des etats de denutrition
IL223181A0 (en) The use of inhibitors of bruton's tyrosine kinase (btk)
FR2920306B1 (fr) Utilisation cosmetique d'un lysat de bifidobacterieum species.
EP2382176A4 (fr) Utilisation d'analogues de curcumine contenant de l'azote pour le traitement de la maladie d'alzheimer
WO2012046030A3 (fr) Inhibiteurs de phosphodiestérase
FR2901467B1 (fr) Prothese anatomique pour le traitement des hernies, telles que hernies inguinales et crurales et autres
FR2915102B1 (fr) Utilisation d'un anticorps anti-cxcr4 pour le traitement du cancer
FR2943249B1 (fr) Utilisation de la decorine pour augmenter la masse musculaire
FR2906716B1 (fr) Utilisation d'une composition cosmetique pour le soin des peaux grasses.
ES2626639T8 (es) Medicamento o composición dermatológica que contiene un extracto peptídico de aguacate destinado al tratamiento y a la prevención del prurito interno
FR2930145B1 (fr) Utilisation d'un extrait de myrte comme depigmentant.
FR2930155B1 (fr) Utilisation d'un extrait de baie, et plus particulierement de wolfberry, a titre d'agent anti-pollution
FR2895677B1 (fr) Utilisation d'un extrait insaponifiable de pulpe vegetale dans le traitement du vieillissement cutane.
EP2398789A4 (fr) Inhibiteurs de bêta-sécrétase de type spiropyrrolidine pour le traitement de la maladie d'alzheimer
FR2920303B1 (fr) Utilisation d'un extrait de boerhavia pour apaiser la peau.
FR2943255B1 (fr) Utilisation cosmetique d'un extrait d'hippophae
FR2920301B1 (fr) Utilisation d'une association hesperidine et microorganisme pour le traitement de la secheresse des matieres keratiniques.
FR2910813B1 (fr) Nouvelle utilisation therapeutique pour le traitement des leucemies
FR2902334B1 (fr) Utilisation d'un extrait de souci dans une composition cosmetique.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20151231